Tekla Capital Management’s Vaxcyte PCVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$9.7M	Buy	194,232 +189,232	+3,785%	+$9.45M	0.38%	58
2023 Q1	$187K	Hold	5,000	–	–	0.01%	166
2022 Q4	$240K	Buy	+5,000	New	+$240K	0.01%	159